Články s príkazom na verejný prístup - Gerard SanacoraĎalšie informácie
Nedostupné nikde: 13
Cortical inhibition, gamma-aminobutyric acid, and major depression: there is plenty of smoke but is there fire?
G Sanacora
Biological psychiatry 67 (5), 397-398, 2010
Príkazy: US National Institutes of Health
The use of ketamine for the treatment of depression in the context of psychotic symptoms: to the editor
CM da Frota Ribeiro, G Sanacora, R Hoffman, R Ostroff
Biological psychiatry 79 (9), e65-e66, 2016
Príkazy: US National Institutes of Health
Macro-and microscale stress–associated alterations in brain structure: translational link with depression
M Banasr, G Sanacora, I Esterlis
Biological Psychiatry 90 (2), 118-127, 2021
Príkazy: US National Institutes of Health, US Department of Veterans Affairs …
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression
LA Averill, CL Averill, R Gueorguieva, S Fouda, M Sherif, KH Ahn, ...
Journal of affective disorders 303, 91-97, 2022
Príkazy: US National Institutes of Health, US Department of Veterans Affairs
Do glutamatergic agents represent a new class of antidepressant drugs? Part 1
G Sanacora
J Clin Psychiatry 70 (10), 1473-1475, 2009
Príkazy: US National Institutes of Health
Effect of concomitant benzodiazepines on the antidepressant effects of ketamine: findings from the RAPID intravenous ketamine study
A Feeney, BB Hoeppner, MP Freeman, M Flynn, DV Iosifescu, MH Trivedi, ...
The Journal of Clinical Psychiatry 84 (1), 43883, 2022
Príkazy: US National Institutes of Health
Authorship credit for large clinical trials
ST Wilkinson, G Sanacora
JAMA 319 (7), 722-723, 2018
Príkazy: US National Institutes of Health
Reply to: ketamine and psychosis history: antidepressant efficacy and psychotomimetic effects Postinfusion
CM da Frota Ribeiro, G Sanacora, R Ostroff
Biological Psychiatry 82 (5), e37, 2017
Príkazy: US National Institutes of Health
In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response
T Holsinger, P Riordan
Annals of Internal Medicine 176 (9), JC105, 2023
Príkazy: Patient-Centered Outcomes Research Institute
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine
DV Iosifescu, MH Trivedi, G Sanacora, SJ Mathew, C DeBattista, ...
J Clin Psychiatry 84 (1), 22m14491, 2023
Príkazy: US National Institutes of Health
Imaging the Effect of Ketamine on Synaptic (SV2A) Density
S Holmes, S Finnema, M Naganawa, N DellaGioia, D Holden, K Fowles, ...
Biological Psychiatry 89 (9), S35, 2021
Príkazy: US Department of Veterans Affairs
116. Results of the NIMH FAST-MAS Phase IIa Proof of Mechanism Study of the Effects of the Selective κ Opioid Antagonist JNJ-67953964 on fMRI Ventral Striatal Activity in …
A Krystal, D Pizzagalli, M Smoski, S Mathew, J Nurnberger, S Lisanby, ...
Biological Psychiatry 85 (10), S48-S49, 2019
Príkazy: US National Institutes of Health
AmericAn Society of clinicAl PSychoPhArmAcology corner
G Sanacora
J Clin Psychiatry 70 (11), 2009
Príkazy: US National Institutes of Health
Dostupné niekde: 112
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
M Popoli, Z Yan, BS McEwen, G Sanacora
Nature Reviews Neuroscience 13 (1), 22-37, 2012
Príkazy: US National Institutes of Health, John D. and Catherine T. MacArthur Foundation
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
RS Duman, GK Aghajanian, G Sanacora, JH Krystal
Nature medicine 22 (3), 238-249, 2016
Príkazy: US National Institutes of Health
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications
S Sen, R Duman, G Sanacora
Biological psychiatry 64 (6), 527-532, 2008
Príkazy: US National Institutes of Health
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders
G Sanacora, G Treccani, M Popoli
Neuropharmacology 62 (1), 63-77, 2012
Príkazy: US National Institutes of Health
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
G Sanacora, CA Zarate, JH Krystal, HK Manji
Nature reviews Drug discovery 7 (5), 426-437, 2008
Príkazy: US National Institutes of Health
Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments
RS Duman, G Sanacora, JH Krystal
Neuron 102 (1), 75-90, 2019
Príkazy: US National Institutes of Health, US Department of Veterans Affairs
The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis
ST Wilkinson, ED Ballard, MH Bloch, SJ Mathew, JW Murrough, A Feder, ...
American journal of psychiatry 175 (2), 150-158, 2018
Príkazy: US National Institutes of Health, US Department of Education, US Department …
Informácie o zverejnení a financovaní sú automaticky vyberané počítačovým programom